BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2276375)

  • 1. [A neuropharmacological study of isoteolin (IST)].
    Markov M; Zheliazkov D
    Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurophoarmacologic profile of an aminotetraline derivative].
    Raĭnova L; Micheva M; Kharalambieva M; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1977; 16(4):211-6. PubMed ID: 590178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A neuropharmacological study of a hydroxazine derivative].
    Ilarionov I; Bantutova I; Iakimova K
    Eksp Med Morfol; 1990; 29(2):28-33. PubMed ID: 2073884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
    Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and toxicological properties of ryodipine.
    Kimenis AA; Vitolina RO; Petersone IO; Germane SK; Briede JL
    Arzneimittelforschung; 1985; 35(4):672-9. PubMed ID: 4015733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 12. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacological profile of MD 790501, a new benzamide derivative.
    Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of endogenous and exogenous GABA.
    Czajka R
    Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacological effects of ivermectin in mice.
    Kanwar RS; Varshneya C
    Indian J Physiol Pharmacol; 1995 Oct; 39(4):421-2. PubMed ID: 8582760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central action of glucagon.
    Morawska D; Sieklucka-Dziuba M; Kleinrok Z
    Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effect of Pavetta crassipes extract on rodents.
    Amos S; Akah PA; Enwerem N; Chindo BA; Hussaini IM; Wambebe C; Gamaniel K
    Pharmacol Biochem Behav; 2004 Apr; 77(4):751-9. PubMed ID: 15099920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.